Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EXUMA Biotech logo — company profile

EXUMA Biotech

Founded 2015 United States West Palm Beach, United States 25 employees Series B Total: $107.00M Big Data, Biotechnology +1

General Information

Company Name EXUMA Biotech
Founded Year 2015
Location United States West Palm Beach, United States +4
Employees 25
Industries Big Data, Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when EXUMA Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EXUMA Biotech

EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, the company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman, and headquarters in West Palm Beach, FL. The latest investment, a $41.00M Series B investment, took place on 21 December 2021 and was led by Americo Financial Life and Annuity. Their focus on Big Data, Biotechnology, and Health Care indicates their innovative approach to revolutionizing cancer treatment. With their strategic positioning and strong financial backing, EXUMA Biotech is poised for continued growth and impact in the biotechnology sector.

Taxonomy: Immuno-Oncology, CAR-T, Cell Therapy, Gene Therapy, Viral Engineering, CAR-NK, Oncology, Immunotherapy

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
21 Dec 2021
Series B •••••• 2
Investor Investor
12 Mar 2020
Venture Round •••••• 1
Investor
08 Jan 2018
Series A •••••• 4
Investor Investor Investor
•••• •••• 		16 Feb 2017

EXUMA Biotech Alternatives & Competitors

EXUMA Biotech vs
Neukio Biotherapeutics
Neukio Biotherapeutics China

Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iP...

Series A
14 employees
Biotechnology
Compare EXUMA Biotech vs Neukio Biotherapeutics
EXUMA Biotech vs
NKGen Biotech, Inc.
NKGen Biotech, Inc. United States

Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.

54 employees
EXUMA Biotech vs
SpecificiT Pharma
SpecificiT Pharma

Pioneering personalized cancer therapies with a novel approach using Minor Histocompatibility Antige...

Seed
0-1 employees
Biotechnology, Health Care
Compare EXUMA Biotech vs SpecificiT Pharma
Also compare with: EXUMA Biotech vs Nectin Therapeutics Nectin Therapeutics

FAQ About EXUMA Biotech

EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, The company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman...
EXUMA Biotech was founded in 2015.
EXUMA Biotech is headquartered in West Palm Beach, United States.
EXUMA Biotech operates in the following industries: Big Data, Biotechnology, Health Care.
EXUMA Biotech has approximately 25 employees.
EXUMA Biotech has completed 4 funding rounds, raising a total of $107.00M. The latest funding stage is Series B.
Top alternatives and competitors to EXUMA Biotech include Neukio Biotherapeutics, NKGen Biotech, Inc., SpecificiT Pharma, Nectin Therapeutics, Link Cell Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EXUMA Biotech and Neukio Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EXUMA Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy